San Francisco-based PharmaCare US Inc. has been hit with a putative class action that alleges the company falsely marketed its product IntenseX as having aphrodisiac properties that increase “sexual power and performance.”
Plaintiff Jonathan Kanfer of West Palm Beach, Florida, claims that no evidence exists to indicate that over-the-counter IntenseX product contains any ingredients that would actually, individually or in combination, provide health or sex-enhancing benefits, according to the complaint filed Jan. 20 in the U.S. District Court for the Southern District of California.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
